Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Wednesday's After-Market Session

Author: Benzinga Insights | March 27, 2024 04:31pm

Gainers

  • Avalo Therapeutics (NASDAQ:AVTX) shares moved upwards by 215.8% to $15.0 during Wednesday's after-market session. The market value of their outstanding shares is at $12.0 million.
  • Fresh2 Group (NASDAQ:FRES) stock moved upwards by 5.26% to $0.6. The company's market cap stands at $14.2 million.
  • Biora Therapeutics (NASDAQ:BIOR) shares rose 5.12% to $1.23. The company's market cap stands at $33.4 million. As per the news, the Q4 earnings report came out yesterday.
  • Athira Pharma (NASDAQ:ATHA) stock rose 5.07% to $2.69. The market value of their outstanding shares is at $103.0 million.
  • Clearside Biomedical (NASDAQ:CLSD) stock rose 4.79% to $1.75. The company's market cap stands at $130.7 million.
  • TFF Pharmaceuticals (NASDAQ:TFFP) stock increased by 4.7% to $6.9. The market value of their outstanding shares is at $16.3 million.

Losers

  • Strata Skin Sciences (NASDAQ:SSKN) stock fell 12.5% to $0.39 during Wednesday's after-market session. The market value of their outstanding shares is at $13.6 million. As per the press release, Q4 earnings came out today.
  • Yield10 Bioscience (NASDAQ:YTEN) stock declined by 9.36% to $0.34. The company's market cap stands at $4.0 million.
  • Modular Medical (NASDAQ:MODD) stock declined by 9.24% to $1.77. The company's market cap stands at $54.8 million.
  • GlycoMimetics (NASDAQ:GLYC) stock fell 8.81% to $2.9. The company's market cap stands at $186.7 million. As per the news, the Q4 earnings report came out today.
  • Titan Pharma (NASDAQ:TTNP) shares fell 5.15% to $7.0. The market value of their outstanding shares is at $5.2 million.
  • Alzamend Neuro (NASDAQ:ALZN) stock declined by 5.01% to $0.99. The company's market cap stands at $6.5 million. The company's, Q3 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALZN ATHA AVTX BIOR CLSD FRES GLYC MODD SSKN TFFP TTNP YTEN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist